Paper36972253
Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
Thiesen AP and 2 others. PLoS One, 2023. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer. Papers, record 36972253. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36972253
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Deep learning neural network image analysis of immunohistochemical protein expression reveals a significantly reduced expression of biglycan in breast cancer.
- PubMed
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Deep Learning | Major topic |
| Image Interpretation, Computer-Assisted | Major topic |
| Female | |
| Humans | |
| Biglycan | |
| Biomarkers, Tumor | |
| Case-Control Studies | |
| Neural Networks, Computer |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25613900 | Proteomics. Tissue-based map of the human proteome. | Science | 2015 | https://conductscience.org/library/papers/25613900 | PubMed |
| 2 | 12153565 | Biglycan isoforms with differences in polysaccharide substitution and core protein in human lung fibroblasts. | Eur J Biochem | 2002 | https://conductscience.org/library/papers/12153565 | PubMed |
| 3 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 4 | 33716731 | Advanced Approaches to Breast Cancer Classification and Diagnosis. | Front Pharmacol | 2020 | https://conductscience.org/library/papers/33716731 | PubMed |
| 5 | 24681892 | Biglycan enhances gastric cancer invasion by activating FAK signaling pathway. | Oncotarget | 2014 | https://conductscience.org/library/papers/24681892 | PubMed |
| 6 | 1968422 | Localization of PGI (biglycan, BGN) and PGII (decorin, DCN, PG-40) genes on human chromosomes Xq13-qter and 12q, respectively. | Genomics | 1990 | https://conductscience.org/library/papers/1968422 | PubMed |
| 7 | 23817524 | Breast cancer normalization induced by embryonic mesenchyme is mediated by extracellular matrix biglycan. | Integr Biol (Camb) | 2013 | https://conductscience.org/library/papers/23817524 | PubMed |
| 8 | 32194659 | Biglycan as a potential diagnostic and prognostic biomarker in multiple human cancers. | Oncol Lett | 2020 | https://conductscience.org/library/papers/32194659 | PubMed |
| 9 | 24223213 | Inhibitory role of the small leucine-rich proteoglycan biglycan in bladder cancer. | PLoS One | 2013 | https://conductscience.org/library/papers/24223213 | PubMed |
| 10 | 33809543 | The Extracellular Small Leucine-Rich Proteoglycan Biglycan Is a Key Player in Gastric Cancer Aggressiveness. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33809543 | PubMed |
| 11 | 21719787 | Small leucine-rich proteoglycans in kidney disease. | J Am Soc Nephrol | 2011 | https://conductscience.org/library/papers/21719787 | PubMed |
| 12 | 12131154 | Quality assurance in immunohistochemistry: results of an interlaboratory trial involving 172 pathologists. | Am J Surg Pathol | 2002 | https://conductscience.org/library/papers/12131154 | PubMed |
| 13 | 33107395 | A Quest for New Cancer Diagnosis, Prognosis and Prediction Biomarkers and Their Use in Biosensors Development. | Technol Cancer Res Treat | 2020 | https://conductscience.org/library/papers/33107395 | PubMed |
| 14 | 25356943 | Expression of elafin in fallopian tubes of ectopic pregnancies is reduced. | Appl Immunohistochem Mol Morphol | 2015 | https://conductscience.org/library/papers/25356943 | PubMed |
| 15 | 22821552 | Biglycan: a multivalent proteoglycan providing structure and signals. | J Histochem Cytochem | 2012 | https://conductscience.org/library/papers/22821552 | PubMed |
| 16 | 33966638 | Inhibition of stromal biglycan promotes normalization of the tumor microenvironment and enhances chemotherapeutic efficacy. | Breast Cancer Res | 2021 | https://conductscience.org/library/papers/33966638 | PubMed |
| 17 | 24341124 | Comparison of HSCORE assessment of endometrial beta3 integrin subunit expression with digital HSCORE using computerized image analysis (ImageJ). | Anal Quant Cytopathol Histpathol | 2013 | https://conductscience.org/library/papers/24341124 | PubMed |
| 18 | 2647739 | Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. | J Biol Chem | 1989 | https://conductscience.org/library/papers/2647739 | PubMed |
| 19 | 25927296 | A potential mechanism for extracellular matrix induction of breast cancer cell normality. | Breast Cancer Res | 2014 | https://conductscience.org/library/papers/25927296 | PubMed |
| 20 | 2212616 | Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. | J Histochem Cytochem | 1990 | https://conductscience.org/library/papers/2212616 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41788706 | Fusion of genomic and pathological data for breast cancer detection using BCDNN. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/41788706 | PubMed |
| 39903727 | BCL6 (B-cell lymphoma 6) expression in adenomyosis, leiomyomas and normal myometrium. | PLoS One | 2025 | https://conductscience.org/library/papers/39903727 | PubMed |
| 37509212 | The Landscape of Small Leucine-Rich Proteoglycan Impact on Cancer Pathogenesis with a Focus on Biglycan and Lumican. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37509212 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| BGN | 633 | PubTator's text mining | https://conductscience.org/library/genes/633 | NCBI Gene |
| ERBB2 | 2064 | PubTator's text mining | https://conductscience.org/library/genes/2064 | NCBI Gene |
| ESR1 | 2099 | PubTator's text mining | https://conductscience.org/library/genes/2099 | NCBI Gene |
| PGR | 5241 | PubTator's text mining | https://conductscience.org/library/genes/5241 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36972253
GET https://conductscience.org/api/papers/v1/36972253/references?page=2